RESTATEMENT (Table)

6 Months Ended

Jun. 30, 2017

Accounting Changes and Error Corrections [Abstract]

Schedule of balance sheet

The following table represents the balance sheet as previously reported, restatement adjustment, and as restated as of June 30, 2017:

				Restatement
	As Previously Filed			Adjustment			As Restated
	(Unaudited)						(Unaudited)
ASSETS
Current Assets:
Cash	$	44,764					$	44,764
Accounts receivable		229,012						229,012
Other receivables		-						-
Vendor notes receivable, net of allowance for doubtful		-						-
collection of $360,993		-						-
Vendor advances receivable		-						-
Inventories, at lower cost or market, principally average cost method		1,550,664						1,550,664
Prepaid expense		133,995						133,995
Total Current Assets		1,958,435			-			1,958,435
Equipment, net of accumulated depreciation of $34,244		211,591			334,153			545,744
Other Assets:		-						-
Licensing agreement, net of $6,250 of accumulated amortization in 2017		229,167						229,167
Goodwill		1,950,816			(1,950,816	)		-
TOTAL ASSETS	$	4,350,009		$	(1,616,663	)	$	2,733,346
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
Current Liabilities:
Accounts payable	$	405,680					$	405,680
Accounts payable - related parties		-						-
Accrued liabilities		103,166						103,166
Convertible note payable, net of debt discount of $356,250 in 2016		1,775,000						1,775,000
Note payable - related party		300,040						300,040
Insurance premium note payable		62,210						62,210
Total Current Liabilities		2,646,096			-			2,646,096
Stockholders' Equity (Deficit):
Common Stock, $0.001 par value, 100,000,000 shares authorized
17,976,175 and 15,754,000 shares issued and outstanding at
June 30, 2017 and  December 31, 2016, respectively		19,168						19,168
Additional paid-in capital		3,546,766						3,546,766
Stock subscription receivable		-						-
Accumulated (Deficit)		(1,862,021	)		(1,616,663	)		(3,478,684	)
Total Stockholders' Equity (Deficit)		1,703,913			(1,616,663	)		87,250
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$	4,350,009		$	(1,616,663	)	$	2,733,346

Schedule of operations

The following table represents the income statement as previously reported, restatement adjustment, and as restated as of June 30, 2017:

	As Previously			Restatement						As Previously			Restatement
	Filed			Adjustment			As Restated			Filed			Adjustment			As Restated
	(3 months)									(6 months)
Gross Sales	$	315,579					$	315,579		$	969,363					$	969,363
Customer incentives, discounts, returns, and allowances		-						-			-						-
Net sales		315,579			-			315,579			969,363			-			969,363
Cost of Goods Sold, includes depreciation and amortization of $32,987 and    $52,408 for the three and six months ended June 30, 2017, respectively		283,309			11,956			295,265			749,742			19,912			769,654
Gross Margin		32,270			(11,956	)		20,314			219,621			(19,912	)		199,709
Operating Expenses
Selling and marketing		270,901						270,901			387,734						387,734
Corporate general and administrative		197,052			180,595			377,647			775,454			180,595			956,049
Employee salaries and related expenses		150,088						150,088			318,075						318,075
Depreciation expense		1,055						1,055			1,434			1,235			2,669
Total operating expenses		619,096			180,595			799,691			1,482,697			181,830			1,664,527
Loss from Operations		(586,826	)		(192,551	)		(779,377	)		(1,263,076	)		(201,742	)		(1,464,818	)
Other Income (Expenses)
Loss on vendor notes receivable collectibility		-			-			-			-			1,414,921			1,414,921
Interest expense		22,741			-			22,741			443,921						443,921
Profit (Loss) before Income Taxes		(609,567	)		(192,551	)		(802,118	)		(1,706,997	)		(1,616,663	)		(3,323,660	)
Provision for Income Taxes
Net Profit (Loss)	$	(609,567	)	$	(192,551	)	$	(802,118	)	$	(1,706,997	)	$	(1,616,663	)	$	(3,323,660	)
Loss per share
Basic and fully diluted:
Weighted average number of shares outstanding		18,425,818			18,425,818			18,425,818			17,653,924			17,653,924			17,653,924
Loss per share	$	(0.03	)	$	(0.01	)	$	(0.04	)	$	(0.10	)	$	(0.09	)	$	(0.19	)

Schedule of stockholders equity

The following table represents the statement of stockholder’s equity (deficit) as previously reported and as restated as of June 30, 2017:

	Common Shares				Additional Paid-In			Preferred		Subscription			Accumulated			Total
	Number		Par Value		Capital			Shares		Receivable			(Deficit)
Balance as of January 1, 2017		15,754,000	$	15,754	$	799,180		$	-	$	(167,500	)	$	(155,024	)	$	492,410
Reverse merger and recapitalization		604,321		604		(604	)		-		-			-			-
Subscriptions collected		-		-					-		167,500			-			167,500
Common stock issued for founder shares		625,000		625		-			-		-			-			625
Common stock issued for cash @ $1.25 per share		2,014,700		2,015		2,516,360			-		-			-			2,518,375
Organizational and fund raising costs		20,000		20		(17,020	)		-		-			-			(17,000	)
Common stock issued for payment of legal fees @ $2.50 per share		49,600		50		123,950			-		-			-			124,000
Licensing agreement		100,000		100		124,900			-		-			-			125,000
Net loss for period ended June 30, 2017 (Restated)		-		-					-		-			(3,323,660	)		(3,323,660	)
Balance as of June 30, 2017 (Restated)		19,167,621	$	19,168	$	3,546,766		$	-	$	-		$	(3,478,684	)	$	87,250

Schedule of cash flows

The following table represents the statement of cash flow as previously reported, restatement adjustment, and as restated as of June 30, 2017:

				Restatement
	As Previously Filed			Adjustment			As Restated
Cash flows from operating activities:
Net (Loss)	$	(1,706,997	)	$	(1,616,663	)	$	(3,323,660	)
Adjustments to reconcile Net (Loss) to Net Cash provided by operations:
Debt discount amortization		356,250			-			356,250
Depreciation and amortization		33,930			21,147			55,077
Uncollectible vendor notes receivable		-			1,414,921			1,414,921
Common stock issued for legal services		-			124,000			124,000
Changes in Current Assets and Liabilities
Vendor advances receivable		155,891			30,595			186,486
Accounts receivable		(208,048	)		-			(208,048	)
Other receivables					-			-
Inventories		(822,112	)		-			(822,112	)
Prepaid expenses		46,767			-			46,767
Accounts payable		349,377			-			349,377
Accrued liabilities		101,474			-			101,474
Net cash used in operating activities		(1,693,468	)		(26,000	)		(1,719,468	)
Cash flows from investing activities
Goodwill, legal fee		(26,000	)		26,000			-
Purchase of equipment		(36,873	)		-			(36,873	)
Net cash used in investing activities		(62,873	)		-			(62,873	)
Cash flow from financing activities
Convertible note payment		(100,000	)		-			(100,000	)
Note payment - related party		(659,960	)		-			(659,960	)
Insurance premium note payments		(118,551	)		-			(118,551	)
Sale of common stock		2,686,500			-			2,686,500
Organization and fundraising costs		(17,000	)		-			(17,000	)
Net cash provided by financing activities		1,790,989			-			1,790,989
Net increase in cash		34,648			-			34,648
Cash, beginning of period		10,116			-			10,116
Cash, end of period	$	44,764		$	-		$	44,764
Supplemental cash flow disclosures
Cash paid during the period for -
Interest	$	5,913		$	-		$	5,913
Income taxes	$	-		$	-		$	-

				Restatement
	As Previously Filed			Adjustment			As Restated
Non-cash investing and financing activities:
Vendor note receivable foreclosure -
Vendor notes receivable	$	2,585,000		$	(1,414,921	)	$	1,170,079
Vendor advances receivable		(96,552	)					(96,552	)
Accounts receivable		(20,965	)					(20,965	)
Inventories		(509,447	)					(509,447	)
Equipment		(187,815	)		(355,300	)		(543,115	)
Goodwill		(1,770,221	)		1,770,221			-
Licensing Agreement		(125,000	)					(125,000	)
Goodwill		125,000						125,000
Other receivables		(20,811	)					(20,811	)
Accounts payable		20,811						20,811
Insurance premium note payable		180,761						180,761
Prepaid expenses		(180,761	)					(180,761	)
Common stock		604						604
Additional paid-in-capital		(604	)					(604	)
	$	-		$	-		$	-